Skip to content

Capricor Therapeutics CAPR Gain (loss) on disposal of assets

Gain (loss) on disposal of assets at other companies

Cabot Corporation logo
Cabot CorporationCBT
-$3M
Unifirst logo
UnifirstUNF
-$233K-3,983%
MYR Group logo
MYR GroupMYRG
$922K-16.3%
CSW Industrials, Inc. logo
CSW Industrials, Inc.CSW
-$345K-790%
Federated Hermes logo
Federated HermesFHI
$413K-57.1%
EPR Properties logo
EPR PropertiesEPR
$1.03M-89.1%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's gain (loss) on disposal of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's gain (loss) on disposal of assets?
Capricor Therapeutics (CAPR) reported gain (loss) on disposal of assets of -$81.14K in Q1 2026.
How has Capricor Therapeutics's gain (loss) on disposal of assets changed year-over-year?
Capricor Therapeutics's gain (loss) on disposal of assets increased by 46.1% year-over-year, from -$150.67K to -$81.14K.
What does gain (loss) on disposal of assets mean?
Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.